PURE Bioscience Announces Distribution Agreement with Quip Laboratories
PURE Bioscience (OTCQB: PURE) has signed a multi-year distribution agreement with Quip Laboratories for its patented SDC (silver dihydrogen citrate) antimicrobial products. The partnership aims to enhance product accessibility across biomedical research, pharmaceutical production, companion animal care, and food processing industries. SDC's dual-action antimicrobial technology works by deactivating membrane proteins and denaturing DNA in microbes, offering a stable shelf life of several years compared to traditional silver-based disinfectants.
PURE Bioscience (OTCQB: PURE) ha firmato un accordo di distribuzione pluriennale con Quip Laboratories per i suoi prodotti antimicrobici brevettati SDC (citrato di diidrogeno d'argento). La partnership mira a migliorare l'accessibilità dei prodotti nei settori della ricerca biomedica, della produzione farmaceutica, della cura degli animali da compagnia e della lavorazione alimentare. La tecnologia antimicrobica a doppia azione di SDC agisce disattivando le proteine della membrana e denaturando il DNA nei microbi, offrendo una stabilità di conservazione di diversi anni rispetto ai disinfettanti tradizionali a base di argento.
PURE Bioscience (OTCQB: PURE) ha firmado un acuerdo de distribución a varios años con Quip Laboratories para sus productos antimicrobianos patentados SDC (citrato de dihidrógeno de plata). La asociación tiene como objetivo mejorar el acceso a los productos en las industrias de investigación biomédica, producción farmacéutica, cuidado de animales de compañía y procesamiento de alimentos. La tecnología antimicrobiana de acción dual de SDC funciona desactivando las proteínas de la membrana y desnaturalizando el ADN en los microbios, ofreciendo una vida útil estable de varios años en comparación con los desinfectantes tradicionales a base de plata.
PURE Bioscience (OTCQB: PURE)는 Quip Laboratories와 특허 받은 SDC (은 이수화 구연산) 항균 제품을 위한 다년간 유통 계약을 체결했습니다. 이번 파트너십은 생의학 연구, 제약 생산, 반려동물 관리 및 식품 가공 산업 전반에 걸쳐 제품 접근성을 향상시키는 것을 목표로 합니다. SDC의 이중 작용 항균 기술은 미생물의 막 단백질을 비활성화하고 DNA를 변성시킴으로써 전통적인 은 기반 소독제에 비해 여러 해 동안 안정적인 유통 기한을 제공합니다.
PURE Bioscience (OTCQB: PURE) a signé un accord de distribution pluriannuel avec Quip Laboratories pour ses produits antimicrobiens brevetés SDC (citrate d'argent dihydrogène). Ce partenariat vise à améliorer l'accessibilité des produits dans les secteurs de la recherche biomédicale, de la production pharmaceutique, des soins aux animaux de compagnie et du traitement des aliments. La technologie antimicrobienne à double action de SDC fonctionne en désactivant les protéines de membrane et en dénaturant l'ADN dans les microbes, offrant une durée de conservation stable de plusieurs années par rapport aux désinfectants traditionnels à base d'argent.
PURE Bioscience (OTCQB: PURE) hat eine mehrjährige Vertriebsvereinbarung mit Quip Laboratories für ihre patentierten SDC (Silberdihydrogencitrat) Antimikrobiellen Produkte unterzeichnet. Die Partnerschaft zielt darauf ab, die Produktverfügbarkeit in den Bereichen biomedizinische Forschung, pharmazeutische Produktion, Pflege von Begleit Tieren und Lebensmittelverarbeitung zu verbessern. Die Antimikrobiell Technologie von SDC mit doppelter Wirkung wirkt, indem sie Membranproteine deaktiviert und die DNA von Mikroben denaturiert, und bietet im Vergleich zu herkömmlichen Silberbasierten Desinfektionsmitteln eine stabile Haltbarkeit von mehreren Jahren.
- Strategic distribution agreement expands market reach in biomedical, pharmaceutical, and food processing sectors
- Partnership leverages Quip Labs' established network and expertise
- Product offers superior shelf life of several years versus traditional silver-based disinfectants
- None.
PURE is pleased to announce the signing of a strategic distribution agreement with Quip Labs, a distinguished leader in solutions for the biomedical research, pharmaceutical production, companion animal care, and food processing industries. This partnership will enhance the accessibility of PURE's innovative products while ensuring superior safety and quality standards across these vital sectors.
“We are incredibly excited to partner with Quip Labs,” said Tim Steffensmeier, VP of Sales at PURE. “This agreement represents a significant step forward in our growth strategy, allowing us to leverage Quip Lab's expertise and established network. Together, we will provide even more comprehensive solutions that meet the biomedical, pharmaceutical, and food processing industries' unique needs while enhancing laboratory animal care.”
The partnership will enable both organizations to combine their resources and knowledge, ultimately delivering greater value to clients and ensuring that the highest quality and compliance standards are maintained throughout the industries in which Quip Labs services.
PURE will attend Quip Labs’ booth at the American Association for Laboratory Animal Science national meeting in
“By joining forces with PURE, we are positioning ourselves to serve our customers better and respond to their needs quickly and efficiently,” added Nick Hidell, Chief Operating Officer at Quip Labs. “We look forward to collaborating with PURE to drive innovation and excellence across our industries.”
How SDC Works
SDC kills microorganisms by two modes of action: 1) the silver ion deactivates structural and metabolic membrane proteins, leading to microbial death; 2) the microbes view SDC as a food source, allowing the silver ion to enter the microbe. Once inside the organism, the silver ion denatures the DNA, which halts the microbe’s ability to replicate and leads to its death. This dual action makes SDC highly and quickly effective against a broad spectrum of microbes. Traditional silver-based disinfectants have short shelf lives – from hours to days. SDC is a stabilized silver ion complex with a shelf life of several years. The unique bond between the silver ions in SDC allows them to remain in solution while making them more bio-available for antimicrobial action.
About Quip Labs
Quip Laboratories is a leading provider of comprehensive facility hygiene solutions for a variety of industries, including the life sciences, healthcare, and food production markets. With a range of proprietary disinfectants and sterilants, as well as a best-in-class suite of decontamination and monitoring services, Quip Labs offers a comprehensive and eco-friendly approach to efficient facility hygiene. To reach out, please visit www.quiplabs.com or call 1.800.424.2436.
About PURE Bioscience, Inc.
PURE focuses on developing and commercializing our proprietary antimicrobial products, primarily in food safety. We provide solutions to combat the health and environmental challenges of pathogens and hygienic control. Our technology platform is based on patented, stabilized ionic silver, and our initial products contain silver dihydrogen citrate, better known as SDC. This broad-spectrum, non-toxic antimicrobial agent formulates well with other compounds. As a platform technology, SDC is distinguished from existing products in the marketplace because of its superior efficacy, reduced toxicity, and mitigation of bacterial resistance. PURE’s mailing address is 771 Jamacha Rd. #512,
Forward-looking Statements: Any statements in this press release that do not describe historical facts may constitute forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Statements in this press release, including quotes from management, concerning the Company’s expectations, plans, business outlook, future performance, future potential revenues, and expected results of the Company’s marketing efforts, the execution of contracts under negotiation, and any other statements concerning assumptions made or expectations as to any future events, conditions, performance or other matters, are “forward-looking statements.” Forward-looking statements inherently involve risks and uncertainties that could cause our results to differ materially from any forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, the Company’s failure to implement or otherwise achieve the benefits of its proposed business initiatives and plans; acceptance of the Company’s current and future products and services in the marketplace, including the Company’s ability to convert successful evaluations and tests for PURE Control and PURE Hard Surface into customer orders and customers continuing to place product orders as expected and to expand their use of the Company’s products; the Company’s ability to maintain relationships with its partners and other counterparties; the Company’s ability to generate sufficient revenues and reduce its operating expenses in order to reach profitability; the Company’s ability to raise the funding required to support its continued operations and the implementation of its business plan; the ability of the Company to develop effective new products and receive required regulatory approvals for such products, including the required data and regulatory approvals required to use its SDC-based technology as a direct food contact processing aid in raw meat processing and to expand its use in OLR poultry processing; competitive factors, including customer acceptance of the Company’s SDC-based products that are typically more expensive than existing treatment chemicals; dependence upon third-party vendors, including to manufacture its products; and other risks detailed in the Company’s periodic report filings with the Securities and Exchange Commission (the SEC), including its Form 10-K for the fiscal year ended July 31, 2024. You should not rely on these forward-looking statements, which speak only as of the date of this press release. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241101647952/en/
Tim Steffensmeier, Vice President of Sales
PURE Bioscience, Inc.
Phone: 619-596-8600 Ext. 170
Source: PURE Bioscience, Inc.
FAQ
What is the new distribution agreement between PURE Bioscience (PURE) and Quip Laboratories?
How does PURE Bioscience's (PURE) SDC antimicrobial technology work?
What industries will PURE Bioscience (PURE) serve through the Quip Labs partnership?
